Biomerica (BMRA) Long-Term Investments (2011 - 2026)

Biomerica has disclosed Long-Term Investments across 16 years of filings, most recently posting $165000.0 for Q1 2026.

• Long-Term Investments for Q1 2026 came in at $165000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Feb 2026 was $165000.0 (changed 0.0% YoY), and the FY2025 annual result was $165000.0, changed 0.0% from the prior year.
• Long-Term Investments came in at $165000.0 for Q1 2026 at Biomerica, roughly flat from $165000.0 in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $165324.0 in Q1 2022 to a low of $165000.0 in Q2 2022.
• The 5-year median for Long-Term Investments is $165000.0 (2022), against an average of $165076.2.
• Peak annual rise in Long-Term Investments reached 0.0% in 2022, while the deepest fall reached 0.2% in 2022.
• Biomerica's Long-Term Investments stood at $165324.0 in 2022, then declined by 0.2% to $165000.0 in 2023, then changed by 0.0% to $165000.0 in 2024, then changed by 0.0% to $165000.0 in 2025, then changed by 0.0% to $165000.0 in 2026.
• The last three Long-Term Investments figures came in at $165000.0 (Q1 2026), $165000.0 (Q4 2025), and $165000.0 (Q3 2025), per Business Quant data.